M&A Deal Summary |
|
|---|---|
| Date | 2025-10-16 |
| Target | George King Bio-Medical |
| Sector | Medical Products |
| Buyer(s) | Precision BioLogic |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Medical Products |
| Employees | 80 |
Precision BioLogic is a developer, manufacturer, and marketer of the CRYOcheck™ line of frozen products used by medical professionals and researchers around the globe to diagnose coagulation disorders. Precision BioLogic was founded in 1983 and is based in Dartmouth, Nova Scotia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Kansas M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-01 |
Affinity Biologicals
Ancaster, Ontario, Canada Affinity Biologicals, Inc. is a manufacturer of 300 reagents and kits used in hemostasis and thrombosis research and diagnostics. Affinity's product line includes an extensive line of coagulation-related antibodies, conjugates, matched-pair antibody sets for immunoassay of human and animal analytes, the VisuLize™ line of complete ELISA kits, and a full line of human plasma products including VisuDep™ Immune-Depleted Factor-Deficient Plasmas, VisuCal™ Calibrator Plasma, and VisuCon™ Control Plasmas. |
Buy | - |
